254 related articles for article (PubMed ID: 18452170)
21. Ethnic differences in prostate cancer.
Kheirandish P; Chinegwundoh F
Br J Cancer; 2011 Aug; 105(4):481-5. PubMed ID: 21829203
[TBL] [Abstract][Full Text] [Related]
22. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
[TBL] [Abstract][Full Text] [Related]
23. Racial differences in screening for prostate cancer in the elderly.
Gilligan T; Wang PS; Levin R; Kantoff PW; Avorn J
Arch Intern Med; 2004 Sep; 164(17):1858-64. PubMed ID: 15451760
[TBL] [Abstract][Full Text] [Related]
24. Racial differences in PSA screening interval and stage at diagnosis.
Carpenter WR; Howard DL; Taylor YJ; Ross LE; Wobker SE; Godley PA
Cancer Causes Control; 2010 Jul; 21(7):1071-80. PubMed ID: 20333462
[TBL] [Abstract][Full Text] [Related]
25. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).
Cohen JH; Schoenbach VJ; Kaufman JS; Talcott JA; Schenck AP; Peacock S; Symons M; Amamoo MA; Carpenter WR; Godley PA
Cancer Causes Control; 2006 Aug; 17(6):803-11. PubMed ID: 16783608
[TBL] [Abstract][Full Text] [Related]
26. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
Hoffman RM; Gilliland FD; Eley JW; Harlan LC; Stephenson RA; Stanford JL; Albertson PC; Hamilton AS; Hunt WC; Potosky AL
J Natl Cancer Inst; 2001 Mar; 93(5):388-95. PubMed ID: 11238701
[TBL] [Abstract][Full Text] [Related]
27. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
28. Cancer mortality in the United States by education level and race.
Albano JD; Ward E; Jemal A; Anderson R; Cokkinides VE; Murray T; Henley J; Liff J; Thun MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1384-94. PubMed ID: 17848670
[TBL] [Abstract][Full Text] [Related]
29. Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial.
Miller EA; Pinsky PF; Black A; Andriole GL; Pierre-Victor D
Prostate; 2018 Aug; 78(11):830-838. PubMed ID: 29667217
[TBL] [Abstract][Full Text] [Related]
30. Survival rates of prostate cancer: black vs white patients.
Ethn Dis; 2003; 13(2):298-9. PubMed ID: 12785430
[No Abstract] [Full Text] [Related]
31. Racial disparities in prostate cancer survival in a screened population: Reality versus artifact.
Kaur D; Ulloa-Pérez E; Gulati R; Etzioni R
Cancer; 2018 Apr; 124(8):1752-1759. PubMed ID: 29370459
[TBL] [Abstract][Full Text] [Related]
32. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
Powell IJ; Schwartz K; Hussain M
Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
[TBL] [Abstract][Full Text] [Related]
33. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
[TBL] [Abstract][Full Text] [Related]
34. Diabetes and prostate cancer screening in black and white men.
Sanderson M; Fowke JH; Lipworth L; Han X; Ukoli F; Coker AL; Blot WJ; Hargreaves MK
Cancer Causes Control; 2013 Oct; 24(10):1893-9. PubMed ID: 23860952
[TBL] [Abstract][Full Text] [Related]
35. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
Eastham JA; Kattan MW
J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
[TBL] [Abstract][Full Text] [Related]
36. Black-white differences in survival from late-stage prostate cancer.
Polednak AP
Ethn Dis; 2003; 13(2):220-5. PubMed ID: 12785419
[TBL] [Abstract][Full Text] [Related]
37. Demographic, Social Support, and Community Differences in Predictors of African-American and White Men Receiving Prostate Cancer Screening in the United States.
Dickey SL; Cormier EM; Whyte J; Graven L; Ralston PA
Public Health Nurs; 2016 Nov; 33(6):483-492. PubMed ID: 26790837
[TBL] [Abstract][Full Text] [Related]
38. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
Godley PA; Schenck AP; Amamoo MA; Schoenbach VJ; Peacock S; Manning M; Symons M; Talcott JA
J Natl Cancer Inst; 2003 Nov; 95(22):1702-10. PubMed ID: 14625261
[TBL] [Abstract][Full Text] [Related]
39. Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey.
Defever K; Platz EA; Lopez DS; Mondul AM
Cancer Causes Control; 2020 Sep; 31(9):851-860. PubMed ID: 32666408
[TBL] [Abstract][Full Text] [Related]
40. Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.
Parikh RB; Robinson KW; Chhatre S; Medvedeva E; Cashy JP; Veera S; Bauml JM; Fojo T; Navathe AS; Malkowicz SB; Mamtani R; Jayadevappa R
JAMA Netw Open; 2020 Sep; 3(9):e2018318. PubMed ID: 32986109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
